<document id="DDI-DrugBank.d210">
    <sentence id="DDI-DrugBank.d210.s5" text="Patients taking low-dose aspirin plus ibuprofen were not studied.">
        <entity charOffset="25-31" id="DDI-DrugBank.d210.s5.e0" text="aspirin" type="brand" />
        <entity charOffset="38-46" id="DDI-DrugBank.d210.s5.e1" text="ibuprofen" type="drug" />
        <pair ddi="false" e1="DDI-DrugBank.d210.s5.e0" e2="DDI-DrugBank.d210.s5.e1" id="DDI-DrugBank.d210.s5.p0" />
    </sentence>
    <sentence id="DDI-DrugBank.d210.s6" text="At steady state, VIOXX 50 mg once daily had no effect on the anti-platelet activity of low-dose (81 mg once daily) aspirin, as assessed by ex vivo platelet aggregation and serum TXB2 generation in clotting blood.">
        <entity charOffset="17-21" id="DDI-DrugBank.d210.s6.e0" text="VIOXX" type="brand" />
        <entity charOffset="115-121" id="DDI-DrugBank.d210.s6.e1" text="aspirin" type="brand" />
        <pair ddi="false" e1="DDI-DrugBank.d210.s6.e0" e2="DDI-DrugBank.d210.s6.e1" id="DDI-DrugBank.d210.s6.p0" />
    </sentence>
    <sentence id="DDI-DrugBank.d210.s7" text="Because of its lack of platelet effects, VIOXX is not a substitute for aspirin for cardiovascular prophylaxis.">
        <entity charOffset="41-45" id="DDI-DrugBank.d210.s7.e0" text="VIOXX" type="brand" />
        <entity charOffset="71-77" id="DDI-DrugBank.d210.s7.e1" text="aspirin" type="brand" />
        <pair ddi="false" e1="DDI-DrugBank.d210.s7.e0" e2="DDI-DrugBank.d210.s7.e1" id="DDI-DrugBank.d210.s7.p0" />
    </sentence>
    <sentence id="DDI-DrugBank.d210.s9" text="Prospective, long-term studies on concomitant administration of VIOXX and aspirin have not been conducted.">
        <entity charOffset="64-68" id="DDI-DrugBank.d210.s9.e0" text="VIOXX" type="brand" />
        <entity charOffset="74-80" id="DDI-DrugBank.d210.s9.e1" text="aspirin" type="brand" />
        <pair ddi="false" e1="DDI-DrugBank.d210.s9.e0" e2="DDI-DrugBank.d210.s9.e1" id="DDI-DrugBank.d210.s9.p0" />
    </sentence>
    <sentence id="DDI-DrugBank.d210.s26" text="Therefore, a starting daily dose of 25 mg of VIOXX should be considered for the treatment of osteoarthritis when VIOXX is co-administered with potent inducers of hepatic metabolism.">
        <entity charOffset="45-49" id="DDI-DrugBank.d210.s26.e0" text="VIOXX" type="brand" />
        <entity charOffset="113-117" id="DDI-DrugBank.d210.s26.e1" text="VIOXX" type="brand" />
        <pair ddi="false" e1="DDI-DrugBank.d210.s26.e0" e2="DDI-DrugBank.d210.s26.e1" id="DDI-DrugBank.d210.s26.p0" />
    </sentence>
    </document>